XTX Topco’s Century Therapeutics IPSC Stock Holding History

XTX Topco’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.9K	Buy	22,518 +7,185	+47%	+$15.1K	﹤0.01%	3313
2025 Q4	$15.3K	Sell	15,333 -12,225	-44%	-$7.46K	﹤0.01%	3119
2025 Q3	$13.7K	Buy	+27,558	New	+$14.9K	﹤0.01%	2391
2025 Q2	–	Sell	-43,514	Closed	-$20.7K	–	2751
2025 Q1	$20.7K	Sell	43,514 -42,479	-49%	-$31.9K	﹤0.01%	2130
2024 Q4	$86.9K	Buy	+85,993	New	+$117K	0.01%	1798
2024 Q1	–	Sell	-14,177	Closed	-$47.1K	–	2072
2023 Q4	$47.1K	Buy	+14,177	New	+$25.8K	0.01%	1242
2023 Q2	–	Sell	-30,862	Closed	-$107K	–	1612
2023 Q1	$107K	Buy	+30,862	New	+$136K	0.02%	1087

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

XTX Topco's IPSC Position: Q1 2026 in Review

XTX Topco increased its Century Therapeutics (IPSC) stake by 47% in Q1 2026, buying an estimated $15.1K and bringing the position to 22,518 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3313.

XTX Topco first reported a position in IPSC in Q1 2023 and has held it in 7 quarters since. The position peaked at $107K in Q1 2023. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

XTX Topco held 22,518 shares of Century Therapeutics worth $50.9K as of Q1 2026.
XTX Topco bought 7,185 Century Therapeutics shares in Q1 2026, an estimated $15.1K.
Century Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3313 holding.
XTX Topco first reported a position in Century Therapeutics in Q1 2023 and has held it in 7 quarters since.
XTX Topco's Century Therapeutics position peaked at $107K in Q1 2023.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.